Is hypoandrogenemia a component of metabolic syndrome in males?

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 1, 2011, Pages 30-35

  Singh, S K ^a   Goyal, R ^a   Pratyush, D D ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

central obesity; hypogonadism; insulin resistance; sex hormone binding globulin; testosterone

Indexed keywords

SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ADULT; ANDROGEN THERAPY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETES MELLITUS; HOMEOSTASIS; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; CHOLESTEROL, HDL; HORMONE REPLACEMENT THERAPY; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 78651433474     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1261918     Document Type: Article

References (40)

1. Alberti KGMM, Zimmet P, Shaw J. The IDF epidemiology task force consensus group: metabolic syndrome: a new worldwide definition. Lancet 2005 366 1059-1062
2. Anderson PJ, Critchley JA, Chan JC, etal. Factor analysis of the metabolic syndrome: obesity vs. insulin resistance as the central abnormality. Int J Obesity 2001 25 1782-1788
3. Barrett TG, Bundey SE. Wolfram (DIDMOAD) syndrome. J Med Genet 1997 34 838-841
4. Bhasin S. Effects of testosterone administration on fat distribution, insulin sensitivity and atherosclerosis progression. Clin Infect Dis 2003 37 S142-S149
5. Bojesen A, Kristensen K, Birkebaek NH, etal. The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 2006 29 1591-1598
6. Boyanov MA, Boneva A, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male 2003 6 17
7. Corona G, Mannucci E, Petrone L, etal. NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus and prevalence of hypogonadism in male patients with sexual dysfunction. J Sex Med 2007 4 1038-1045
8. Corona G, Mannucci E, Petrone L, etal. A comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction. J Sex Med 2007 4 789-796
9. Dhindsa S, Prabhakar S, Sethi M, etal. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 2004 89 5462-5468
10. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005 28 2745-2749
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 499-502
12. Ganesh HK, Vijaya Sarathi HA, George J, etal. Prevalence of hypogonadism in patients with Type 2 Diabetes mellitus in an Asian Indian study group. Endocr Pract 2009 15 513-520
13. Guay AT. The emerging link between hypogonadism and metabolic syndrome. J Androl 2009 30 370-376
14. Haffner SM, Karhapaa P, Mykkanen L, etal. Insulin resistance, body fat distribution, and sex hormones in men. Diabetes 1994 43 212-219
15. Haffner SM, Valdez RA, Stern MP, etal. Obesity, body fat distribution and sex hormones in men. Int J Obes Relat Metab Disord 1993 17 643-649
16. Haring R, Henry Vlzke, Stephan BF, etal. Prediction of metabolic syndrome by low serum testosterone levels in men results from the Study of Health in Pomerania. Diabetes 2009 58 2027-2031
17. Harman SM, Metter EJ, Tobin JD, etal. Longitudinal effects of aging on serum total and free testosterone levels in healthy men: Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001 86 724-731
18. Heufelder AE, Saad F, Bunck MC, etal. 52-Week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. J Androl 2009 30 726-733
19. Isidori AM, Caprio M, Strollo F, etal. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab 1999 84 3673-3680
20. Kapoor D, Goodwin E, Channer KS, etal. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006 154 6 899-906
21. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005 26 833-876
22. Khaw KT, Dowsett M, Folkerd E, etal. Endogenous testosterone and mortality due to all causes, cardiovascular disease and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 2007 116 2694-2701
23. Laaksonen DE, Niskanen L, Punnonen K, etal. Sex hormones, inflammation and the metabolic syndrome. Eur J Endo 2003 149 601-607
24. Laaksonen DE, Niskanen L, Punnonen K, etal. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004 27 5 1036-1041
25. Malkin CJ, Pugh PJ, Jones TH, etal. Testosterone for secondary prevention in men with ischaemic heart disease. Q J Med 2003 96 521-529
26. Marin P, Holmang S, Jonsson L, etal. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 1992 16 991-997
27. Matthews DR, Hosker JP, Rudenski AS, etal. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419
28. Medlej R, Wasson J, Baz P, etal. Diabetes Mellitus and Optic atrophy: A study of Wolfram Syndrome in the Lebanese population. J Clin Endocrinol Metab 2004 89 1656-1661
29. Oh JY, Barrett-Conner E, Wedick NM, etal. Endogenous sex hormones and the development of type 2 diabetes in older men and women: The Rancho Bernardo Study. Diabetes Care 2002 25 55-60
30. Pitteloud N, Hardin M, Dwyer AA, etal. Increasing insulin resistance is associated with a decrease in leydig cell testosterone secretion in men. J Clin Endocrinol Metab 2005 90 2636-2641
31. Phillips GB, Jing T, Heymsfield SB. Relationships in men of sex hormones, insulin, adiposity and risk factors for myocardial infarction. Metabolism 2003 52 784-790
32. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988 37 1595-1607
33. Stefan N, Schick F, Hring H-U. Sex hormone-binding globulin and risk of type 2 diabetes. N Engl J Med 2009 361; 27 2675-2676
34. Stellato RK, Feldman HA, Hamdy O, etal. Testosterone, sex hormonebinding globulin and the development of type 2 diabetes in middle-aged Men. Diabetes Care 2000 23 490-494
35. Svartberg J, Muhlen DV, Sundsfjord J. Waist circumference and testosterone levels in community dwelling men. The Tromso study. Eur J Epidemiol 2004 19 657-663
36. Swerdlow AJ, Higgins CD, Schoemaker MJ, etal. The UK Clinical Cytogenetics Group: Mortality in patients with Klinefelter Syndrome in Britain: a cohort study. J Clin Endocrinol Metab 2005 90 6516-6522
37. Tsai EC, Atsumoto AM, Fujimoto WY, etal. Association of Bioavailable, Free and Total testosterone with insulin resistance influence of sex hormone-binding globulin and body fat. Diabetes Care 2004 27 861-868
38. Vermeulen A, Kaufman JM. Diagnosis of hypogonadism in the aging male. Aging Male 2002 5 170-176
39. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999 84 3666-3672
40. World Health Organization. Definition, diagnosis and classification of Diabetes Mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of Diabetes Mellitus Geneva WHO Department of Noncommunicable Disease Surveillance 1999 http://www.who.int 1-59 http://www.who.int